{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:37:12Z","timestamp":1793371032275,"version":"4.5.0"},"reference-count":340,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019401","name":"Hidradenitis Suppurativa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.08.125","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:43:18Z","timestamp":1792503798000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines of care for the management of hidradenitis suppurativa"],"prefix":"10.1016","author":[{"given":"Haley B.","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howa","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsy","family":"Frazer-Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Daniel","family":"Daveluy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher John","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Hightower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.V.","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Plotke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Shive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy A.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig N.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.08.125_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2026.08.125_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2026.08.125_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"Guyatt","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2026.08.125_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2025.2373","article-title":"Prevalence of hidradenitis suppurativa: a meta-analysis of global hidradenitis suppurativa atlas studies","volume":"161","author":"Bouazzi","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamadermatol.2020.5467","article-title":"Global harmonization of morphological definitions in hidradenitis suppurativa for a proposed glossary","volume":"157","author":"Frew","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamadermatol.2025.4652","article-title":"Standardization of lesion classification and assessment by investigators in clinical trials for hidradenitis suppurativa: a consensus exercise using a modified Delphi approach","volume":"162","author":"Garg","year":"2026","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5021\/ad.23.090","article-title":"Review of scoring systems for hidradenitis suppurativa","volume":"36","author":"Kim","year":"2024","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/bjd.14475","article-title":"Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process","volume":"175","author":"Ingram","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jaad.2025.08.041","article-title":"Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensus","volume":"93","author":"Westerkam","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000531926","article-title":"Resorcinol 10% as a promising therapeutic option for mild hidradenitis suppurativa: a prospective, randomized, open study","volume":"9","author":"Katoulis","year":"2023","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jaad.2026.08.125_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1159\/000530758","article-title":"Clindamycin-benzoyl peroxide gel compared with clindamycin lotion for hidradenitis suppurativa: a randomized controlled assessor-blinded intra-patient pilot study","volume":"239","author":"Aarts","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000518540","article-title":"LAight(R) therapy significantly enhances treatment efficacy of 16 weeks of topical clindamycin solution in Hurley I and II hidradenitis suppurativa: results from period A of RELIEVE, a multicenter randomized, controlled trial","volume":"238","author":"Schultheis","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaad.2017.07.008","article-title":"Topical 15% resorcinol for hidradenitis suppurativa: an uncontrolled prospective trial with clinical and ultrasonographic follow-up","volume":"77","author":"Pascual","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/bjd.19337","article-title":"Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance","volume":"183","author":"Molinelli","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000515450","article-title":"Topical 15% resorcinol is associated with high treatment satisfaction in patients with mild to moderate hidradenitis suppurativa","volume":"238","author":"Docampo-Sim\u00f3n","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1346-8138.16275","article-title":"Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: a cohort study","volume":"49","author":"Cordero-Ramos","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2230.2009.03377.x","article-title":"Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa","volume":"35","author":"Boer","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2025.10.149","article-title":"Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: results from a randomized, double-blind, vehicle-controlled phase 2 study","volume":"94","author":"Porter","year":"2026","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bjd\/ljae495","article-title":"Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa","volume":"192","author":"Schell","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000524762","article-title":"Efficacy of subantimicrobial, modified-release doxycycline compared to regular-release doxycycline for the treatment of hidradenitis suppurativa","volume":"8","author":"Kontochristopoulos","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jaad.2026.08.125_bib26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/bjd\/ljaf361","article-title":"Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trial","volume":"193","author":"Aarts","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ijd.15459","article-title":"Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study","volume":"60","author":"Jorgensen","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendon\u00e7a","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.19578","article-title":"Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study","volume":"184","author":"Yao","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2020.12.089","article-title":"The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: results of a prospective European cohort study","volume":"85","author":"van Straalen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/ced.12933","article-title":"Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up","volume":"41","author":"Dessinioti","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bjd.19867","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study","volume":"185","author":"Bettoli","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ced.14388","article-title":"Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation","volume":"46","author":"Caposiena Caro","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2179368","article-title":"Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa","volume":"34","author":"Segura Palacios","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamadermatol.2023.6201","article-title":"Efficacy and durability of intravenous ertapenem therapy for recalcitrant hidradenitis suppurativa","volume":"160","author":"Nosrati","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkv361","article-title":"Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients","volume":"71","author":"Join-Lambert","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2026.08.125_bib40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/ijd.14036","article-title":"Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa","volume":"57","author":"Braunberger","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ced.14119","article-title":"Spironolactone therapy for hidradenitis suppurativa","volume":"45","author":"Quinlan","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","article-title":"Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa","volume":"80","author":"Golbari","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib44","article-title":"Efficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis","volume":"10","author":"Gangidi","year":"2024","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib45","article-title":"Spironolactone in hidradenitis suppurativa: a single-center","volume":"10","author":"Masson","year":"2024","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000526019","article-title":"Effectiveness and safety of acitretin for the treatment of hidradenitis suppurativa, predictors of clinical response: a cohort study","volume":"239","author":"S\u00e1nchez-D\u00edaz","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1203475416659858","article-title":"Acitretin","volume":"21","author":"Tan","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib50","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1111\/jdv.18706","article-title":"Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa","volume":"37","author":"Molinelli","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"40","author":"Boer","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jdv.16023","article-title":"Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials","volume":"34","author":"van der Zee","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib53","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jamadermatol.2021.2905","article-title":"Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial","volume":"157","author":"Glatt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib55","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib57","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaad.2018.05.015","article-title":"Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials","volume":"79","author":"Kimball","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib58","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jdv.18632","article-title":"Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa","volume":"37","author":"Tzellos","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib59","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamasurg.2021.3655","article-title":"Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa: the SHARPS randomized clinical trial","volume":"156","author":"Bechara","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib60","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.08.125_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/09546634.2012.683767","article-title":"Long-term efficacy of infliximab in hidradenitis suppurativa","volume":"23","author":"Paradela","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib63","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib64","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1684\/ejd.2012.1795","article-title":"Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa","volume":"22","author":"Lesage","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2016.08.036","article-title":"Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa","volume":"76","author":"Montaudie","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib66","first-page":"310","article-title":"Three-week infliximab dosing is associated with improved disease control in severe hidradenitis suppurativa: a retrospective study","volume":"94","author":"Islam","year":"2026","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib67","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jamadermatol.2021.0220","article-title":"Comparing the effectiveness and safety associated with infliximab vs infliximab-abda therapy for patients with hidradenitis suppurativa","volume":"157","author":"Westerkam","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jaad.2019.09.071","article-title":"High-dose, high-frequency infliximab: a novel treatment paradigm for hidradenitis suppurativa","volume":"82","author":"Ghias","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib69","article-title":"Infliximab in hidradenitis suppurativa: a systematic review and meta-analysis","volume":"35","author":"Shih","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib70","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaad.2019.05.022","article-title":"Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa","volume":"81","author":"Oskardmay","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.08.125_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib73","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0625.2009.00967.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial","volume":"19","author":"Pelekanou","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib74","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","article-title":"A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa","volume":"60","author":"Lee","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib76","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib77","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/jdv.19252","article-title":"Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: a phase 2 randomized study","volume":"37","author":"Kimball","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib78","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13555-023-00913-3","article-title":"Efficacy and safety of risankizumab for the treatment of hidradenitis suppurativa: a phase 2, randomized, placebo-controlled trial","volume":"13","author":"Kimball","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2026.08.125_bib79","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/bjd\/ljaf398","article-title":"Vilobelimab to improve clinical outcomes of moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind, placebo-controlled randomised trial","volume":"194","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib80","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaad.2024.12.046","article-title":"Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: results from a phase 2, randomized, placebo-controlled study","volume":"92","author":"Ackerman","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib81","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaad.2016.06.001","article-title":"Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa","volume":"75","author":"Wong","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib82","article-title":"Prednisone and amoxicillin\/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study","volume":"10","author":"Gibson","year":"2024","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib83","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ad.2019.01.030","article-title":"Systemic steroids in the management of moderate-to-severe hidradenitis suppurativa","volume":"111","author":"Duarte","year":"2020","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.jaad.2026.08.125_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijwd.2020.02.007","article-title":"Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa","volume":"6","author":"Savage","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib85","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjd.14086","article-title":"Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients","volume":"174","author":"Nazary","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib86","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/ijd.16804","article-title":"Azathioprine in hidradenitis suppurativa with inflammatory phenotype: a case series of 11 patients","volume":"62","author":"Lopez Riquelme","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib87","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1016\/j.jid.2021.07.121","article-title":"LB791 Avacopan, a highly selective small molecule inhibitor of c5a receptor, in patients with hidradenitis suppurativa: initial results from a randomized, double-blind, placebo-controlled, phase 2 study (aurora)","volume":"141","author":"Kirby","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib88","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/DSS.0000000000004604","article-title":"Surgical deroofing in the management of hidradenitis suppurativa alone or as an adjunct to medical therapies","volume":"51","author":"Vu","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","article-title":"Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions","volume":"63","author":"van der Zee","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib90","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/DSS.0000000000004498","article-title":"CO 2 laser versus surgical deroofing for the treatment of hidradenitis suppurativa tunnels: a comparative multicentric, retrospective study","volume":"51","author":"Sechi","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib91","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ajd.14375","article-title":"Predictors of wound healing after surgical deroofing in hidradenitis suppurativa","volume":"65","author":"Pham","year":"2024","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib92","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/jdv.19810","article-title":"Deroofing: a safe, effective and well-tolerated procedure in patients with hidradenitis suppurativa","volume":"38","author":"Krajewski","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib93","first-page":"698","article-title":"Deroofing followed by thorough sinus tract excision: a modified surgical approach for hidradenitis suppurativa","volume":"17","author":"Dahmen","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2026.08.125_bib94","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jamadermatol.2021.4741","article-title":"Patient impressions and outcomes after clinic-based hidradenitis suppurativa surgery","volume":"158","author":"Ravi","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib95","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/DSS.0000000000000806","article-title":"Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients","volume":"42","author":"Kohorst","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib96","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ajd.14624","article-title":"Hidradenitis suppurativa deroofing surgery outcomes including pain scores, surface area reduction and patient satisfaction in an Australian cohort","volume":"67","author":"Mortimore","year":"2026","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib97","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s003840050159","article-title":"Extent of surgery and recurrence rate of hidradenitis suppurativa","volume":"13","author":"Ritz","year":"1998","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jaad.2026.08.125_bib98","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/bjd\/ljad327","article-title":"Factors influencing patient experience during incision and drainage procedures in hidradenitis suppurativa: an analysis of patient-reported outcomes","volume":"189","author":"Revankar","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib99","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1468-3083.2011.04203.x","article-title":"Mild to moderate hidradenitis suppurativa treated with local excision and primary closure","volume":"26","author":"van Rappard","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib100","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/jdv.12952","article-title":"Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients","volume":"29","author":"Blok","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib101","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1524-4725.2010.01763.x","article-title":"Surgical treatment of hidradenitis suppurativa: experiences and recommendations","volume":"36","author":"Bieniek","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib102","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042728-200802000-00013","article-title":"Hidradenitis suppurativa: importance of early treatment; efficient treatment with electrosurgery","volume":"34","author":"Aksakal","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib103","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib104","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","article-title":"Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization","volume":"36","author":"Hazen","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0190-9622(96)90441-7","article-title":"Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing","volume":"34","author":"Finley","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib106","first-page":"113","article-title":"CO2 laser for suppurative hidradenitis of the vulva","volume":"36","author":"Sherman","year":"1991","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","article-title":"Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study","volume":"41","author":"Mikkelsen","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1994.tb08559.x","article-title":"Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique","volume":"131","author":"Lapins","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib109","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mjd.2002.124601","article-title":"Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa","volume":"47","author":"Lapins","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/bjs.1800740535","article-title":"Treatment of hidradenitis suppurativa with the carbon dioxide laser","volume":"74","author":"Dalrymple","year":"1987","journal-title":"Br J Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib111","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/dsu.12400","article-title":"Two-stage surgery for hidradenitis suppurativa: staged artificial dermis and skin grafting","volume":"40","author":"Yamashita","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib112","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bjps.2014.04.032","article-title":"Surgical treatment of severe hidradenitis suppurativa of the axilla: thoracodorsal artery perforator (TDAP) flap versus split skin graft","volume":"67","author":"Wormald","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ijd.13393","article-title":"Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report","volume":"56","author":"Wollina","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1524-4725.2011.02157.x","article-title":"Management of severe anogenital acne inversa (hidradenitis suppurativa)","volume":"38","author":"Wollina","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/DSS.0000000000001668","article-title":"Hidradenitis suppurativa after radical surgery-long-term follow-up for recurrences and associated factors","volume":"44","author":"Walter","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib116","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/SAP.0b013e3181da1c4f","article-title":"Treatment of axillary hidradenitis with transposition flaps: a 6-year experience","volume":"64","author":"Varkarakis","year":"2010","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib117","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/micr.20918","article-title":"Superior and inferior gluteal artery perforator flaps in reconstruction of gluteal and perianal\/perineal hidradenitis suppurativa lesions","volume":"31","author":"Unal","year":"2011","journal-title":"Microsurgery"},{"key":"10.1016\/j.jaad.2026.08.125_bib118","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ijd.13969","article-title":"Two-stage surgical repair in 31 patients with stage II-III hidradenitis suppurativa","volume":"57","author":"Tchero","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib119","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1054\/bjps.1999.3285","article-title":"Chronic axillary hidradenitis--the efficacy of wide excision and flap coverage","volume":"53","author":"Soldin","year":"2000","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/2292550319826087","article-title":"Posterior arm perforator flap for axillary reconstruction after hidradenitis suppurativa excision","volume":"27","author":"Sirvan","year":"2019","journal-title":"Plast Surg (Oakv)"},{"key":"10.1016\/j.jaad.2026.08.125_bib121","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/BCR.0000000000000531","article-title":"Surgical management of hidradenitis suppurativa: a 14-year retrospective review of 98 consecutive patients","volume":"38","author":"Romanowski","year":"2017","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2017.01.055","article-title":"The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): retrospective analysis of 74 patients","volume":"77","author":"Posch","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib123","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.anplas.2018.01.003","article-title":"Evaluation of the mobility of the shoulder and quality of life after perforator flaps for recalcitrant axillary hidradenitis","volume":"64","author":"Nail-Barthelemy","year":"2019","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.jaad.2026.08.125_bib124","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/SAP.0b013e3182840831","article-title":"Surgical treatment of extensive sacrococcygeal hidradenitis suppurativa with triangular closure technique","volume":"73","author":"Mutaf","year":"2014","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib125","article-title":"Surgical management of acne inversa","volume":"22","author":"Mirza","year":"2012","journal-title":"J Pakistan Assoc Dermatologists"},{"key":"10.1016\/j.jaad.2026.08.125_bib126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1479-666X(05)80006-X","article-title":"Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases","volume":"3","author":"Mandal","year":"2005","journal-title":"Surgeon"},{"key":"10.1016\/j.jaad.2026.08.125_bib127","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijsu.2017.12.018","article-title":"Men, main victims of hidradenitis suppurativa (a prospective cohort study)","volume":"50","author":"Maghsoudi","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib128","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bjps.2015.05.025","article-title":"Promising long-term outcomes of the reused skin-graft technique for chronic gluteal hidradenitis suppurativa","volume":"68","author":"Maeda","year":"2015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bjps.2016.05.004","article-title":"Improving outcomes in hidradenitis suppurativa","volume":"70","author":"Brierley","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib130","first-page":"173","article-title":"Surgical treatment of chronic gluteal hidradenitis suppurativa: reused skin graft technique","volume":"29","author":"Kuo","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/tjps.TJPS_6_17","article-title":"Surgically treating hidradenitis suppurativa that does not respond to medical treatment","volume":"26","author":"Horoz","year":"2018","journal-title":"Turk J Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib132","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bjps.2015.12.004","article-title":"Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience","volume":"69","author":"Humphries","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib133","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jdv.14770","article-title":"Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures","volume":"32","author":"Deckers","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib134","doi-asserted-by":"crossref","first-page":"370e","DOI":"10.1097\/PRS.0000000000000080","article-title":"Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device","volume":"133","author":"Chen","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PRS.0b013e3182268c38","article-title":"The thoracodorsal artery perforator flap in the treatment of axillary hidradenitis suppurativa: effect on preservation of arm abduction","volume":"128","author":"Busnardo","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib136","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00268-017-4091-7","article-title":"35-year experience with surgical treatment of hidradenitis suppurativa","volume":"41","author":"Burney","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib137","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00268-008-9845-9","article-title":"Surgical approach to extensive hidradenitis suppurativa in the perineal\/perianal and gluteal regions","volume":"33","author":"Balik","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib138","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/120347540400800102","article-title":"Axillary hidradenitis suppurativa: a further option for surgical treatment","volume":"8","author":"Altmann","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib139","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-12-9","article-title":"A review of wide surgical excision of hidradenitis suppurativa","volume":"12","author":"Alharbi","year":"2012","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ad.2022.10.045","article-title":"Wide excision in hidradenitis suppurativa. Does it modify the course of disease?","volume":"114","author":"Butr\u00f3n-Bris","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2026.08.125_bib141","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000527400","article-title":"Patterns of surgical recurrence in patients with hidradenitis suppurativa","volume":"239","author":"Cuenca-Barrales","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib142","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/DSS.0000000000004349","article-title":"Presurgical mapping with ultra-high frequency ultrasound of hidradenitis suppurativa lesions treated with wide local excision and secondary intention healing","volume":"51","author":"Michelucci","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib143","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ced\/llae515","article-title":"Effectiveness of wide local excision and secondary intention healing in hidradenitis suppurativa: a single-centre study on quality of life and mental health outcomes","volume":"50","author":"Michelucci","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib144","first-page":"769","article-title":"The impact of surgery on quality of life in hidradenitis suppurativa: results from a prospective single-center study","volume":"15","author":"Ocker","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jaad.2026.08.125_bib145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bjps.2015.03.002","article-title":"The versatility of the islanded posterior arm flap for regional reconstruction around the axilla","volume":"68","author":"Schmidt","year":"2015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib146","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib147","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1468-3083.2007.02459.x","article-title":"Acne inversa of the anogenital region: early radical surgical excision with plastic defect coverage is treatment of choice","volume":"22","author":"Prandl","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib148","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00266-010-9544-4","article-title":"Experience using the thoracodorsal artery perforator flap in axillary hidradentitis suppurativa cases","volume":"34","author":"Ortiz","year":"2010","journal-title":"Aesthet Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib149","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/SAP.0b013e31828ea7cb","article-title":"Radical surgical resection combined with lymphadenectomy-directed antimicrobial therapy yielding cure of severe axillary hidradenitis","volume":"70","author":"Nesmith","year":"2013","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib150","doi-asserted-by":"crossref","DOI":"10.1590\/0100-6991e-20181719","article-title":"Radical resection and local coverage of hidradenitis suppurativa - acne inversa: analysis of results","volume":"45","author":"Mendes","year":"2018","journal-title":"Rev Col Bras Cir"},{"key":"10.1016\/j.jaad.2026.08.125_bib151","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/SAP.0000000000001664","article-title":"Pedicled thoracodorsal artery perforator and muscle-sparing latissimus dorsi flaps in the axillary reconstruction after hidradenitis suppurativa excision: functional and aesthetic issues","volume":"81","author":"Marchesi","year":"2018","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib152","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/SAP.0000000000001658","article-title":"Outcome of pedicled thoracodorsal artery perforator flap in the surgical treatment of stage II and III hidradenitis suppurativa of axilla","volume":"81","author":"Elgohary","year":"2018","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib153","article-title":"Immediate and delayed reconstruction after excision of axillary hidradenitis suppurativa using a propeller flap","volume":"7","author":"Elboraey","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.jaad.2026.08.125_bib154","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0032-1333323","article-title":"Islanded perforator flaps in the reconstruction of hidradenitis suppurativa defects","volume":"29","author":"Egemen","year":"2013","journal-title":"J Reconstr Microsurg"},{"key":"10.1016\/j.jaad.2026.08.125_bib155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SAP.0000000000000584","article-title":"Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa","volume":"77","author":"DeFazio","year":"2016","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib156","first-page":"835","article-title":"Surgical approach to extensive hidradenitis suppurativa","volume":"37","author":"B\u00fcy\u00fcka\u015fik","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib157","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.3390\/jcm14175945","article-title":"Surgical treatment of axillary hidradenitis suppurativa using preliminary defect closure and two sliding Island triangular skin-subcutaneous flaps from the arm and chest","volume":"14","author":"Bieniek","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib158","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ced\/llae246","article-title":"Surgical outcomes of hidradenitis suppurativa: evaluating factors influencing recurrence and complications after 284 complete excisions","volume":"49","author":"Chang","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ASW.0000000000000237","article-title":"Hidradenitis suppurativa: radical surgical excisions with staged reconstructions: a single-surgeon retrospective review of 71 patients","volume":"37","author":"Judge","year":"2024","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jaad.2026.08.125_bib160","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jbcr\/irac189","article-title":"Evaluation of outcomes following surgical treatment of hidradenitis suppurativa","volume":"44","author":"Romanowski","year":"2023","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib161","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jdin.2024.04.005","article-title":"Treatment of hidradenitis suppurativa with 755-nm alexandrite laser hair removal: a randomized controlled trial","volume":"16","author":"Sidhom","year":"2024","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.08.125_bib162","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jaad.2021.10.060","article-title":"Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: a controlled prospective clinical study","volume":"87","author":"Molinelli","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib163","article-title":"Efficacy and tolerability of long-pulse Alexandrite laser hair removal for hidradenitis suppurativa","author":"Fradet","year":"2021","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib164","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2020.04.117","article-title":"Treatment of hidradenitis suppurativa using a long-pulsed hair removal neodymium:yttrium-aluminium-garnet laser: a multicenter, prospective, randomized, intraindividual, comparative trial","volume":"84","author":"Naouri","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib165","first-page":"901","article-title":"Laser hair removal alters the disease course in mild hidradenitis suppurativa","volume":"16","author":"Vossen","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2026.08.125_bib166","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40257-020-00537-9","article-title":"Botulinum toxin type B for hidradenitis suppurativa: a randomised, double-blind, placebo-controlled pilot study","volume":"21","author":"Grimstad","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib167","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1111\/jdv.20611","article-title":"Botulinum toxin type A efficacy on pain and suppuration in hidradenitis suppurativa","volume":"39","author":"Goandal","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib168","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/DSS.0000000000002112","article-title":"Intralesional triamcinolone may not be beneficial for treating acute hidradenitis suppurativa lesions: a double-blind, randomized, placebo-controlled trial","volume":"46","author":"Fajgenbaum","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib169","article-title":"Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa","volume":"10","author":"Salvador-Rodr\u00edguez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaad.2026.08.125_bib170","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15710","article-title":"Intralesional steroid injections to target sinus tract fibrosis in hidradenitis suppurativa: results from an ultrasound-based retrospective study","volume":"35","author":"Sechi","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib171","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series","volume":"75","author":"Riis","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib172","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/09546634.2019.1655524","article-title":"Intralesional corticosteroid injection for the treatment of hidradenitis suppurativa: a multicenter retrospective clinical study","volume":"32","author":"Garcia-Martinez","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib173","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15068","article-title":"Ultrasound-guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: a prospective study","volume":"34","author":"Iannone","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib174","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13901","article-title":"Intralesional ultrasound-guided combined treatment with triamcinolone plus lincomycin in hidradenitis suppurativa: a pilot study","volume":"33","author":"Fania","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/12034754231188319","article-title":"Efficacy and patient satisfaction associated with intramuscular triamcinolone therapy for acute flares of hidradenitis suppurativa","volume":"27","author":"Benesh","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib176","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000499934","article-title":"Intralesional triamcinolone for fistulous tracts in hidradenitis suppurativa: an uncontrolled prospective trial with clinical and ultrasonographic follow-Up","volume":"236","author":"Alvarez","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib177","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/ijd.17858","article-title":"Intralesional clindamycin and triamcinolone for hidradenitis suppurativa: a targeted therapeutic approach for rapid inflammation control-a prospective case series","volume":"64","author":"Giorgio","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib178","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/ijd.12936","article-title":"A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa","volume":"55","author":"Yildiz","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib179","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jaad.2024.09.006","article-title":"Pain management in hidradenitis suppurativa","volume":"91","author":"Surapaneni","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2026.08.125_bib181","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14919","article-title":"Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy","volume":"34","author":"Iannone","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib182","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib183","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib184","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/1346-8138.15411","article-title":"Clinical characteristics of hidradenitis suppurativa patients in Okinawa, Japan: differences between East Asia and Western countries","volume":"47","author":"Omine","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib186","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000508528","article-title":"Thyroid disease and active smoking may be associated with more severe hidradenitis suppurativa: data from a prospective cross sectional single-center study","volume":"237","author":"Liakou","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib187","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jdv.17857","article-title":"Incidence and remission rates of self-reported hidradenitis suppurativa - a prospective cohort study conducted in Danish blood donors","volume":"36","author":"Kjaersgaard Andersen","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib188","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2017.04.006","article-title":"A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa","volume":"87","author":"Dessinioti","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2026.08.125_bib189","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2016.07.041","article-title":"The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: an institutional retrospective cohort study","volume":"76","author":"Denny","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","article-title":"Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity","volume":"61","author":"Canoui-Poitrine","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib191","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/ced.14612","article-title":"Smoking cessation outcomes in patients with hidradenitis suppurativa: a retrospective analysis","volume":"46","author":"Siddiquee","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib192","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00403-021-02233-y","article-title":"Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients","volume":"314","author":"Macklis","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib193","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ced\/llae386","article-title":"Real-world data about secukinumab in hidradenitis suppurativa: tobacco pack years an underestimated factor","volume":"50","author":"Abu Rached","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib194","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000545833","article-title":"The dose-response relationship between tobacco smoking and hidradenitis suppurativa: results from an observational study of 1,689 patients","volume":"241","author":"Chastagner","year":"2025","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib195","article-title":"Demographic features, clinical characteristics, and comorbid relation in hidradenitis suppurativa: a population-based study","volume":"11","author":"Kaya","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaad.2026.08.125_bib196","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study","volume":"214","author":"Brocard","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib197","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.08.010","article-title":"Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa","volume":"84","author":"Hessam","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2026.08.125_bib198","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaad.2020.04.092","article-title":"Efficacy of oral zinc and nicotinamide as maintenance therapy for mild\/moderate hidradenitis suppurativa: a controlled retrospective clinical study","volume":"83","author":"Molinelli","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib199","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/09546634.2020.1714538","article-title":"Vitamin D deficiency and hidradenitis suppurativa: the impact on clinical severity and therapeutic responsivity","volume":"32","author":"Fabbrocini","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib200","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/jdv.12857","article-title":"Verneuil's disease, innate immunity and vitamin D: a pilot study","volume":"29","author":"Guillet","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib201","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaad.2023.02.018","article-title":"Assessing the ethics of prior authorization denials and step therapy policies in dermatology","volume":"90","author":"Sedghi","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjmed.2025.08.018","article-title":"Adverse effects of health plan prior authorization on clinical effectiveness and patient outcomes: a systematic review","volume":"139","author":"Murphy","year":"2026","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/bjd\/ljaf151","article-title":"The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis","volume":"193","author":"Folkmann","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib204","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jamadermatol.2025.2298","article-title":"Risk of new-onset and recurrent depression and anxiety among patients with hidradenitis suppurativa","volume":"161","author":"Holgersen","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib205","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib206","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaad.2018.11.035","article-title":"Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasound observations","volume":"80","author":"Caposiena Caro","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib207","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12792","article-title":"Clindamycin as unique antibiotic choice in hidradenitis suppurativa","volume":"32","author":"Rosi","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib208","doi-asserted-by":"crossref","first-page":"515","DOI":"10.5021\/ad.2021.33.6.515","article-title":"Clindamycin mono-therapy of hidradenitis suppurativa patients: a single-center retrospective study","volume":"33","author":"An","year":"2021","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib209","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib211","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15161","article-title":"Dapsone in hidradenitis suppurativa: a case series of 56 patients","volume":"34","author":"L\u00f3pez-Llunell","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib212","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.36849\/JDD.4936","article-title":"Dapsone to treat moderate-to-severe hidradenitis suppurativa: a retrospective case-series","volume":"22","author":"Baroudi","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib213","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/bjd.15739","article-title":"Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients","volume":"178","author":"Delaunay","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib214","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2020.01.007","article-title":"Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and 1-year follow-up in 28 consecutive patients","volume":"88","author":"Delage","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib216","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3390\/antibiotics11111573","article-title":"The effect of Dalbavancin in moderate to severe hidradenitis suppurativa","volume":"11","author":"Molinelli","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jaad.2026.08.125_bib217","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09546634.2019.1592100","article-title":"Metformin use in hidradenitis suppurativa","volume":"31","author":"Jennings","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib218","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib219","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.36849\/JDD.2020.5447","article-title":"Metformin as adjunctive therapy for pediatric patients with hidradenitis suppurativa","volume":"19","author":"Moussa","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib221","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib222","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","article-title":"Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3-year results of a phase 3 open-label extension study","volume":"80","author":"Zouboulis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib223","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/bjd\/ljae469","article-title":"Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial","volume":"192","author":"Kimball","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib224","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/exd.14789","article-title":"Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: a prospective cohort study","volume":"32","author":"Flora","year":"2023","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib225","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamadermatol.2025.1976","article-title":"Efficacy and safety of medical interventions for moderate to severe hidradenitis suppurativa: a living systematic review and network meta-analysis","volume":"161","author":"Garg","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib226","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jdv.20617","article-title":"Efficacy and safety of biologics for hidradenitis suppurativa: a network meta-analysis of phase III trials","volume":"40","author":"Calabrese","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib227","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jdv.70265","article-title":"Short-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: a systematic review and NMA","volume":"40","author":"Naik","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib228","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib229","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib230","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000521860","article-title":"An anti-interleukin-17A monoclonal antibody, ixekizumab, in the treatment of resistant hidradenitis suppurativa: a case series","volume":"8","author":"Esme","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jaad.2026.08.125_bib231","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bjd\/ljae144","article-title":"Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial","volume":"191","author":"Alavi","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib232","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/09546634.2020.1776208","article-title":"Effectiveness of ustekinumab for moderate-to-severe hidradenitis suppurativa: a case series","volume":"33","author":"Valenzuela-Ubi\u00f1a","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib233","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14054","article-title":"Effectiveness and safety of ustekinumab in patients with hidradenitis suppurativa using intravenous induction","volume":"33","author":"S\u00e1nchez-Mart\u00ednez","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib234","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000501075","article-title":"Ustekinumab with intravenous infusion: results in hidradenitis suppurativa","volume":"236","author":"Roman\u00ed","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib235","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/09546634.2020.1755008","article-title":"Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review","volume":"33","author":"Montero-Vilchez","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib236","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bjd.21066","article-title":"High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa","volume":"187","author":"Jiang","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib237","first-page":"319","article-title":"Ustekinumab in the management of hidradenitis suppurativa: a retrospective study","volume":"21","author":"Hollywood","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib238","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib239","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","article-title":"Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study","volume":"4","author":"Kennedy","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib240","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001047","article-title":"Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial","volume":"6","author":"Ducourau","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.jaad.2026.08.125_bib241","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gutjnl-2019-319758","article-title":"Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial","volume":"69","author":"Roblin","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2026.08.125_bib242","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib243","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"van der Zee","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib244","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.3390\/jcm10204742","article-title":"Colchicine improves clinical outcomes and quality of life in hidradenitis suppurativa patients: a retrospective study","volume":"10","author":"Liakou","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ijd.13428","article-title":"Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients","volume":"56","author":"Armyra","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib246","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09546634.2015.1088128","article-title":"Cyclosporine treatment of severe hidradenitis suppurativa--A case series","volume":"27","author":"Anderson","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib247","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jdcr.2023.05.017","article-title":"Hydroxychloroquine for the treatment of hidradenitis suppurativa","volume":"37","author":"Brant","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2026.08.125_bib248","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaad.2017.02.026","article-title":"Apremilast in the treatment of moderate to severe hidradenitis suppurativa: a case series of 9 patients","volume":"76","author":"Weber","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib249","first-page":"170","article-title":"Apremilast for the treatment of mild-to-moderate hidradenitis suppurativa in a prospective, open-label, phase 2 study","volume":"18","author":"Kerdel","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","article-title":"Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial","volume":"80","author":"Vossen","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib251","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300155","article-title":"Brepocitinib, zimlovisertib, and ropsacitinib in hidradenitis suppurativa","volume":"3","author":"Kimball","year":"2024","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaad.2026.08.125_bib252","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamadermatol.2022.6266","article-title":"Surgical procedural definitions for hidradenitis suppurativa developed by expert Delphi consensus","volume":"159","author":"Bui","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib253","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/028443101750523230","article-title":"Surgical treatment of hidradenitis suppurativa","volume":"35","author":"Bohn","year":"2001","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib254","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archderm.1965.01600180082016","article-title":"Temporary x-ray epilation therapy of chronic axillary hidradenitis suppurativa","volume":"92","author":"Zeligman","year":"1965","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.1955.01540260063013","article-title":"Hidradenitis suppurativa of the adult and its management","volume":"71","author":"Steiner","year":"1955","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.jaad.2026.08.125_bib256","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1148\/54.1.74","article-title":"Hidradenitis suppurativa axillaris; an analysis of 54 cases treated with roentgen rays","volume":"54","author":"Schenck","year":"1950","journal-title":"Radiology"},{"key":"10.1016\/j.jaad.2026.08.125_bib257","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9619.1000146","article-title":"Radiation therapy for chronic hidradenitis suppurativa","volume":"4","author":"Patel","year":"2013","journal-title":"J Nucl Med Radiat Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib258","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/jdv.15406","article-title":"Effectiveness, safety and tolerability of drainage and punch-trocar-assisted cryoinsufflation (cryopunch) in the treatment of inflammatory acute fluid collections in hidradenitis suppurativa patients","volume":"33","author":"Molina-Leyva","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib259","article-title":"Non-surgical treatment of hidradenitis suppurativa: the role of cryotherapy","volume":"10","author":"Dell'Antonia","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaad.2026.08.125_bib260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2230.2003.01238.x","article-title":"Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy","volume":"28","author":"Bong","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib261","first-page":"430","article-title":"Safety and efficacy of intense pulsed light with radiofrequency in United States hidradenitis suppurativa patients","volume":"21","author":"Lyons","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib262","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/09546634.2019.1677842","article-title":"Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)","volume":"32","author":"Wilden","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib263","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1684\/ejd.2020.3920","article-title":"Intense pulsed light treatment for hidradenitis suppurativa: a within-person randomized controlled trial","volume":"30","author":"Andersen","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib264","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09546634.2017.1387226","article-title":"Intense pulsed light treatment for patients with hidradenitis suppurativa: beware treatment with resorcinol","volume":"29","author":"Theut Riis","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib265","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v105.43543","article-title":"LAight therapy is an effective and gentle treatment in adolescents suffering from hidradenitis suppurative: results from 96 patients using real-world data","volume":"105","author":"Strobel","year":"2025","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib266","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13450","article-title":"The efficacy and safety of endo-radiofrequency for the treatment of hidradenitis suppurativa","volume":"29","author":"Behrangi","year":"2023","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.jaad.2026.08.125_bib267","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/ced.14905","article-title":"Pilot study of fractional microneedling radiofrequency for hidradenitis suppurativa assessed by clinical response and histology","volume":"47","author":"Yang","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib268","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaad.2018.06.032","article-title":"Aggravation of mild axillary hidradenitis suppurativa by microwave ablation: results of a randomized intrapatient-controlled trial","volume":"80","author":"Vossen","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib269","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1111\/j.1365-2230.2008.03094.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: report of five cases","volume":"34","author":"Sotiriou","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib270","first-page":"381","article-title":"Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: preliminary results","volume":"10","author":"Schweiger","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib271","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/c2pp25124h","article-title":"A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications","volume":"12","author":"Calzavara-Pinton","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jaad.2026.08.125_bib272","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ad.2013.10.016","article-title":"Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases","volume":"105","author":"Andino Navarrete","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2026.08.125_bib273","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/bjd.13385","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach","volume":"172","author":"Valladares-Narganes","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib274","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jdermsci.2016.12.014","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy with 5-aminolevulinic acid and 630nm laser beam","volume":"85","author":"Su\u00e1rez Valladares","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2026.08.125_bib275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/phpp.12709","article-title":"Ultrasound-guided photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective study of 41 patients","volume":"38","author":"Gamissans","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2026.08.125_bib276","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1039\/c6pp00082g","article-title":"Photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective follow-up study in 7 patients and a review of the literature","volume":"15","author":"Agut-Busquet","year":"2016","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jaad.2026.08.125_bib277","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s43630-024-00656-w","article-title":"Assessment of therapeutic response to photodynamic therapy with the Zn-Phthalocyanine RLP068\/Cl versus topical Clindamycin in patients affected by hidradenitis suppurativa: a comparative clinical pilot study","volume":"23","author":"Rosi","year":"2024","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jaad.2026.08.125_bib278","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/DSS.0000000000003510","article-title":"An open-label, prospective, pilot study of hypertonic saline for hidradenitis suppurativa","volume":"48","author":"Porter","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib279","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","article-title":"Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study","volume":"34","author":"Buimer","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib280","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1582","article-title":"Advanced wound management approaches in hidradenitis suppurativa postsurgical lesions","volume":"6","author":"Michelucci","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.jaad.2026.08.125_bib281","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15483","article-title":"Single use negative-pressure wound therapy compared to standard care in patients after carbon dioxide laser surgery for hidradenitis suppurativa","volume":"35","author":"Grimstad","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.08.125_bib282","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3390\/polym17192563","article-title":"Synthetic electrospun fiber matrix in the management of acute wounds following excision of hidradenitis suppurativa lesions: a prospective pilot study","volume":"17","author":"Madueke","year":"2025","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jaad.2026.08.125_bib283","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (VOICE) project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib284","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bjd\/ljac018","article-title":"Pain experiences among those living with hidradenitis suppurativa: a qualitative study","volume":"188","author":"Orenstein","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib285","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1159\/000533740","article-title":"The influence of pain on reduced quality of life in patients with hidradenitis suppurativa: a single-center retrospective study","volume":"239","author":"Li","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib286","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib287","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","article-title":"Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]","volume":"21","author":"Patel","year":"2017","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jaad.2026.08.125_bib288","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamadermatol.2020.5857","article-title":"Expert knowledge, attitudes, and practices in management of hidradenitis suppurativa pain","volume":"157","author":"Jedrzejczak","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib289","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the brief pain inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.jaad.2026.08.125_bib290","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/j.pain.0000000000001758","article-title":"Graded chronic pain scale revised: mild, bothersome, and high-impact chronic pain","volume":"161","author":"Von Korff","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jaad.2026.08.125_bib291","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2026.08.125_bib292","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3390\/jcm9124046","article-title":"Prevalence of neuropathic pain and related characteristics in hidradenitis suppurativa: a cross-sectional study","volume":"9","author":"Garcovich","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib293","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000533262","article-title":"Correlation between PainDETECT questionnaire and quantitative sensory testing for the detection of neuropathic pain in hidradenitis suppurativa","volume":"240","author":"Speck","year":"2024","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.08.125_bib294","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamadermatol.2021.2918","article-title":"Prevalence of central sensitization in patients with hidradenitis suppurativa","volume":"157","author":"Aarts","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib295","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/AJP.0000000000000113","article-title":"Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample","volume":"31","author":"Neblett","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2026.08.125_bib296","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00403-025-03943-3","article-title":"Comparing maximum and average numerical rating scale pain scores in hidradenitis suppurativa","volume":"317","author":"Li","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib297","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jpain.2012.09.011","article-title":"Evaluation of the psychometric properties of the revised short-form McGill pain questionnaire","volume":"13","author":"Lovejoy","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.jaad.2026.08.125_bib298","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/bjd\/ljad215","article-title":"Healthcare experiences among patients with hidradenitis suppurativa: a qualitative study","volume":"189","author":"Sow","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib299","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/12034754211024157","article-title":"Hidradenitis suppurativa from a patient perspective including symptoms and self-treatment","volume":"25","author":"Huang","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jamadermatol.2020.4494","article-title":"Pain severity and management of hidradenitis suppurativa at US emergency department visits","volume":"157","author":"Taylor","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib301","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bjd.14266","article-title":"Self-reported pain management in hidradenitis suppurativa","volume":"174","author":"Ring","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib302","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/12034754241308245","article-title":"Pain self-management strategies for hidradenitis suppurativa patients: an in-person survey study","volume":"29","author":"Huang","year":"2025","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2026.08.125_bib303","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1080\/09546634.2020.1822501","article-title":"Pain management modalities for hidradenitis suppurativa: a patient survey","volume":"33","author":"Fernandez","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2026.08.125_bib304","first-page":"153","article-title":"Self-reported pain alleviating methods in patients with hidradenitis suppurativa","volume":"112","author":"Ravn Jorgensen","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed"},{"key":"10.1016\/j.jaad.2026.08.125_bib305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2020.09.039","article-title":"Pain management in hidradenitis suppurativa and a proposed treatment algorithm","volume":"85","author":"Savage","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib306","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","article-title":"Pain management in patients with hidradenitis suppurativa","volume":"73","author":"Horvath","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib307","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/der2.122","article-title":"A practical, comprehensive guide to pain management hidradenitis suppurativa","volume":"3","author":"Li","year":"2022","journal-title":"Dermatol Rev"},{"key":"10.1016\/j.jaad.2026.08.125_bib308","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00403-025-04121-1","article-title":"Empathy, expertise, and expeditious communication: identifying how people with hidradenitis suppurativa experience outpatient palliative care","volume":"317","author":"Soltoff","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib309","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2026.08.125_bib310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12967-024-04853-0","article-title":"Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study","volume":"22","author":"Verde","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib311","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.medcli.2023.11.007","article-title":"Liraglutide for the treatment of obesity among patients with hidradenitis suppurativa","volume":"162","author":"Nicolau","year":"2024","journal-title":"Med Clin"},{"key":"10.1016\/j.jaad.2026.08.125_bib312","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/bjd\/ljae216","article-title":"Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life","volume":"191","author":"Lyons","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib313","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3830","article-title":"Impact of bariatric surgery on hidradenitis suppurativa","volume":"101","author":"Canard","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib314","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1111\/jdv.20392","article-title":"Impact of semaglutide use in obese and diabetic patients with hidradenitis suppurativa","volume":"39","author":"Posada Posada","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib315","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.36849\/JDD.9569","article-title":"An open-label, single-center proof of concept study evaluating the efficacy and safety of tirzepatide for moderate to severe hidradenitis suppurativa","volume":"24","author":"Acosta-Madiedo","year":"2025","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib316","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamadermatol.2025.2723","article-title":"Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa","volume":"161","author":"Gouvrion","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib317","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/ijd.70191","article-title":"Glucagon-like peptide-1 receptor agonists are associated with reduced disease severity and pain in hidradenitis suppurativa: a retrospective study","volume":"65","author":"Islam","year":"2026","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib318","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2340\/00015555-1800","article-title":"The influence of body weight on the prevalence and severity of hidradenitis suppurativa","volume":"94","author":"Kromann","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib319","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/nu11081781","article-title":"The safety and impact of a model of intermittent, time-restricted circadian fasting (\"Ramadan fasting\") on hidradenitis suppurativa: insights from a multicenter, observational, cross-over, pilot, exploratory study","volume":"11","author":"Damiani","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jaad.2026.08.125_bib320","first-page":"2706","article-title":"Mediterranean diet, lifestyle and quality of life in Sardinian patients affected with hidradenitis suppurativa","volume":"11","author":"Velluzzi","year":"2021","journal-title":"J Public Health Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib321","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/nu14030551","article-title":"Potential benefits of the mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population","volume":"14","author":"Lorite-Fuentes","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jaad.2026.08.125_bib322","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jdv.19726","article-title":"Diet and physical activity as risk-reducing factors for hidradenitis suppurativa","volume":"38","author":"Bouwman","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib323","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/nu11010057","article-title":"Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease","volume":"11","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jaad.2026.08.125_bib324","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3390\/medicina60122107","article-title":"The impact of diet on hidradenitis suppurativa severity: a cross-sectional case-control study","volume":"60","author":"Kesik","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jaad.2026.08.125_bib325","first-page":"371","article-title":"Interest of brewer's yeast-exclusion diet in the management of hidradenitis suppurativa","volume":"7","author":"Colboc","year":"2016","journal-title":"J Clin Exp Dermatol Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib326","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.surg.2013.04.018","article-title":"New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer's yeast-exclusion diet","volume":"154","author":"Cannistr\u00e0","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jaad.2026.08.125_bib327","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.surg.2019.12.015","article-title":"Treatment of hidradenitis suppurativa: surgery and yeast (Saccharomyces cerevisiae)-exclusion diet. Results after 6 years","volume":"167","author":"Aboud","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.jaad.2026.08.125_bib328","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.4081\/dr.2019.8243","article-title":"Secondary prevention of hidradenitis suppurativa","volume":"11","author":"Kurzen","year":"2019","journal-title":"Dermatol Rep"},{"key":"10.1016\/j.jaad.2026.08.125_bib329","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jaad.2015.07.042","article-title":"Diet in the prevention of hidradenitis suppurativa (acne inversa)","volume":"73","author":"Danby","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib330","first-page":"749","article-title":"An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by hidradenitis suppurativa: our experience","volume":"155","author":"Donnarumma","year":"2020","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.08.125_bib331","first-page":"111","article-title":"Beneficial effects of staphage lysate in the treatment of chronic recurrent hidradenitis suppurativa","volume":"38","author":"Angel","year":"1987","journal-title":"Surg Forum"},{"key":"10.1016\/j.jaad.2026.08.125_bib332","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa","volume":"150","author":"Kirby","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib333","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00403-023-02576-8","article-title":"Patient perspectives of wound care management in hidradenitis suppurativa","volume":"315","author":"Poondru","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib334","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/bjd.17101","article-title":"Impact of hidradenitis suppurativa on work loss, indirect costs and income","volume":"181","author":"Tzellos","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib335","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMp2117582","article-title":"Step Therapy's Balancing Act - protecting patients while addressing high drug prices","volume":"386","author":"Sachs","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.08.125_bib336","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","article-title":"Diagnostic delay in hidradenitis suppurativa is a global problem","volume":"173","author":"Saunte","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib337","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00403-025-04485-4","article-title":"Diversity in U.S. hidradenitis suppurativa clinical trials: systematic review and meta-analysis","volume":"318","author":"Bagaruka","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.08.125_bib338","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.36849\/JDD.9066","article-title":"Disparities in hidradentitis suppurativa clinical trials: an Updated Review of ClinicalTrials.gov from 2020 to 2024","volume":"24","author":"Choi","year":"2025","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib339","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jdin.2023.11.016","article-title":"Lack of association of exogenous testosterone administration with exacerbation of preexisting hidradenitis suppurativa","volume":"15","author":"Kamal","year":"2024","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.08.125_bib340","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jaad.2026.02.024","article-title":"Incidence of hidradenitis suppurativa in transgender and cisgender individuals: a multicenter matched cohort study","volume":"94","author":"Smith","year":"2026","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.125_bib341","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2024.11.071","article-title":"North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations","volume":"92","author":"Alhusayen","year":"2025","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:28:53Z","timestamp":1793370533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226036108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":340,"alternative-id":["S0190962226036108"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.125","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines of care for the management of hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}